about-us

Rising Healthcare Investments To Support Growth Of Cytogenetic Systems Market

The Global Cytogenetic Systems Market was valued at USD 2.54 Billion in 2020 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 8.2% between 2021 to 2028. Cytogenetics is the branch of biological studies which specifically deals with the study of number chromosomes present in the cell and cell behavior. It also concerns with abnormalities caused due to fluctuation in number of chromosomes in cell. The cytogenetics have applications in the detection and treatment of the diseases such as down syndrome, cancer, Cri du Chat syndrome and other genetic disorders. It also helps to diagnose the risk of missing chromosome or presence of extra chromosome. The cytogenetic systems are used to conduct this cytogenetic analysis.

The rising prevalence of the genetic disorders and other target diseases are majorly contributing to the market growth. The upsurge in cancer treatment requirements owing to rise in number of the cancer patients are contributing to the market growth. The cytogenetic systems are increasingly being demanded by the clinical and pathological testing are propelling the market growth.

Cytogenetic Systems Market Dynamics

The cytogenetic systems market is broadly classified among technique, applications, and end-users. The technology segment is further fragmented into comparative genomic hybridization, in situ hybridization fluorescence in situ hybridization, and other techniques. Among these comparative genomic hybridization holds the largest market share owing to rise in laboratory automation.

The COVID-19 outbreak has treated the healthcare facilities of all the nations across the globe. The governments are increasingly investing in the healthcare and pharmaceutical industry to strengthen the healthcare infrastructure and provide appropriate healthcare facilities. The high-cost requirement of the cytogenetic systems can be overcome by the rise in investments in clinical & research laboratories. The rising investments in healthcare industry by the leading economies are estimated to fuel the global cytogenetic systems market in the coming years.

The key cytogenetic systems manufactures are Danaher Corporation, Agilent Technologies F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc, PerkinElmer Inc, Abbott Laboratories, Illumina, Inc., Oxford Gene Technology, Bio-Rad Laboratories and Applied Spectral Imaging. Regionally, North-America holds the dominant position. The increasing prevalence of the genetic disorders & cancer, rise in number of geriatric population and upsurge in healthcare expenditure are contributing to the regional dominance.